Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors

J Santiprabhob, K Chokephaibulkit, P Khantee… - Cytokine, 2020 - Elsevier
Background Lipodystrophy is common in HIV-infected patients receiving protease inhibitors
(PIs), stavudine, and zidovudine. Adipocytokines may be altered in lipodystrophy. We …
被引用次数：5 相关文章

Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors.

J Santiprabhob, K Chokephaibulkit, P Khantee… - 2020 - cabidigitallibrary.org
Background: Lipodystrophy is common in HIV-infected patients receiving protease inhibitors
(PIs), stavudine, and zidovudine. Adipocytokines may be altered in lipodystrophy. We …

Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors

J Santiprabhob, K Chokephaibulkit, P Khantee… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Lipodystrophy is common in HIV-infected patients receiving protease inhibitors
(PIs), stavudine, and zidovudine. Adipocytokines may be altered in lipodystrophy. We …

Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors.

J Santiprabhob, K Chokephaibulkit, P Khantee… - Cytokine, 2020 - europepmc.org
Background Lipodystrophy is common in HIV-infected patients receiving protease inhibitors
(PIs), stavudine, and zidovudine. Adipocytokines may be altered in lipodystrophy. We …

Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors

J Santiprabhob, K Chokephaibulkit, P Khantee… - …, 2020 - mahidol.elsevierpure.com
Background: Lipodystrophy is common in HIV-infected patients receiving protease inhibitors
(PIs), stavudine, and zidovudine. Adipocytokines may be altered in lipodystrophy. We …